Emerging Concepts About Prenatal Genesis, Aberrant Metabolism, and Treatment Paradigms in Polycystic Ovary Syndrome

The document from the 8th Annual Meeting of the Androgen Excess and PCOS Society discussed the prenatal origins, metabolic dysfunctions, and treatment approaches for polycystic ovary syndrome (PCOS). It suggested that PCOS, which is a significant cause of anovulation-related infertility and is associated with obesity, type 2 diabetes, and cardiovascular disease, may originate prenatally and be influenced by factors such as inflammation and genetic susceptibility. The document also noted that early metabolic dysfunction is a trait in girls who are likely to develop PCOS and that prenatal testosterone exposure may contribute to PCOS traits in adulthood. Treatment discussions included the use of statins, lifestyle interventions, and metformin as first-line therapies, with metformin being particularly beneficial for obese women. For infertility, a combination of metformin with clomiphene citrate or letrozole was discussed, and a multidisciplinary approach was recommended for managing hirsutism. The document emphasized the importance of understanding PCOS pathogenesis for developing new treatments and improving symptom management.